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Urinary acidiﬁcation serves the major 
purpose of excreting acid stemming from 
daily metabolism — about 70 mmol per 
day. This process is mediated mainly by 
the action of electrogenic vacuolar-type 
H+-ATPases that convey the hydroly-
sis of adenosine triphosphate (ATP) 
to pumping protons across the plasma 
membrane.1,2 In the kidney, such H+-
ATPases are found in many epithelial 
cells lining the nephron and collecting 
duct system. In the proximal tubule, H+-
ATPases are involved in the ﬁrst step of 
bicarbonate reabsorption from the urine 
as well as in the acidiﬁcation of endocytic 
vesicles. In the collecting duct system 
(that is, the connecting tubule, cortical 
and outer medullary collecting duct, and 
initial inner medullary collecting duct), 
H+-ATPases are found mainly in inter-
calated cells, where these pumps can be 
localized in the luminal membrane of 
acid-secretory type A intercalated cells 
and in the basolateral and/or luminal 
side of type B and non-A/non-B inter-
calated cells, respectively (Figure 1).
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H+-ATPases mediate urinary acidification along the collecting duct, 
and mutations in their B1 and a4 subunits result in distal renal tubular 
acidosis. The pathomechanisms by which these mutations affect pump 
activity are only poorly understood. Common polymorphisms may 
impair pump activity and may link the pump to a higher risk for alkaline 
urine and the development of kidney stones.
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H+-ATPases are multi-subunit pro-
tein complexes that consist in humans 
of at least 14 subunits with often mul-
tiple isoforms.2 The expression of these 
isoforms may be tissue or cell speciﬁc; 
in some cases multiple isoforms also 
are expressed in the same cell but with 
distinct subcellular localization.3,4 It 
is assumed that speciﬁc isoforms are 
involved in targeting and regulation of 
diﬀerent subsets of pumps, as indicated 
by experiments with yeast vacuolar-type 
H+-ATPases.1,2 The subunits of the pro-
ton pump are organized in two domains, 
a membrane-bound V0 domain and a 
cytosolic V1 domain. The V0 domain 
forms the proton translocation pore, 
whereas the V1 domain binds and 
hydrolyzes ATP, which induces a con-
formational change in the V0 domain 
conveyed through a connecting stalk 
structure. Proton pump activity can 
be regulated by several mechanisms: 
assembly and disassembly of the V1 and 
V0 domains, changes in the eﬃciency of 
the coupling of ATP to proton pumping, 
and traﬃcking into and retrieval from 
the membrane.1,2 Again, some of these 
regulatory mechanisms seem to be dif-
ferent between subunit isoforms.
The biological importance of H+-
ATPases is underlined by the fact that 
genetic knockout of the ubiquitous 
proteolipid subunit ATP6V0C (c sub-
unit) leads to early embryonic death 
due to impaired nidation.5 In humans, 
at least three diﬀerent genes have been 
found to be mutated in rare inherited 
diseases. Mutations of ATP6V0A3 (a3 
subunit) cause infantile osteopetrosis;6,7 
a renal phenotype of these patients and 
corresponding knockout mice has not 
been reported yet, despite the expression 
of this gene in the kidney. Mutations in 
ATP6V1B1 (B1 subunit) or ATP6V0A4 
(a4 subunit) are responsible for syn-
dromes of distal renal tubular acidosis 
(dRTA), which are often associated with 
progressive sensorineural deafness due 
to the extrarenal expression of these sub-
units in the inner ear.8,9 The B1 subunit, 
often (wrongly) referred to also as the 
kidney-specific subunit, is expressed 
mostly in the kidney (all types of inter-
calated cells), but also in the epididymis, 
lung, and inner ear. Similarly, the a4 iso-
form is highly expressed in the kidney 
(present in most epithelial cells along the 
nephron), the epididymis, and the inner 
ear.10 Patients carrying homozygous 
mutations in the ATP6V1B1 and 
ATP6V0A4 genes often present early 
after birth with hypokalemic metabolic 
acidosis, an inappropriately alkaline 
urine, a high susceptibility to dehydra-
tion, hypercalciuria, and progressive 
hearing loss. Less severe cases may be 
identiﬁed later in life because of nephro-
calcinosis or kidney stones.
Alkaline urine pH and the occurrence 
of calcium kidney stones are closely 
linked in the general population, as is 
indicated by many studies in patients 
and animal models.11,12 At least two 
mechanisms may favor the develop-
ment of calcium stones in this setting: 
the lower solubility of calcium in alka-
line urine, and an incipient or overt 
metabolic acidosis as part of a renal 
tubular acidosis syndrome. Forms of 
complete and incomplete renal tubular 
acidosis have been frequently detected in 
patients with a high (re)occurrence rate 
of calcium kidney stones. Thus, inap-
propriate urinary acidification along 
the collecting duct mediated by proton 
pumps could contribute to the develop-
ment of calcium kidney stones, not only 
in patients with homozygous mutations 
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but also in a more general population. 
However, little is known about the func-
tional consequences of proton pump 
subunit mutations detected in dRTA 
patients. Moreover, polymorphisms for 
some of these subunit isoforms have been 
described, but their functional relevance 
has not been investigated. The func-
tional investigation of particular subu-
nit isoforms is hampered by the fact that 
mammalian cells often express more than 
one isoform of a given pump subunit and 
that diﬀerent isoforms may substitute for 
at least some functions of the missing or 
defective isoform. We and others found 
that in a mouse model deﬁcient in the B1 
subunit (Atp6v1b1 knockout), residual 
proton pump activity and urinary acidi-
ﬁcation are preserved in the collecting 
duct.13–15 This ﬁnding was surprising 
at ﬁrst glance, but we detected that the 
B2 isoform was partially substituting 
for the loss of the B1 isoform. Interest-
ingly, the B2 isoform cannot substitute 
for all functions, as is indicated by the 
fact that induction of metabolic acidosis 
in these animals results in severe dRTA 
and impaired urinary acidiﬁcation, and 
no stimulation of H+-ATPase activity 
could be observed in intercalated cells 
from knockout animals. Similarly, angio-
tensin II stimulates H+-ATPase activity 
in outer medullary collecting duct inter-
calated cells from normal animals but not 
from mice lacking the B1 isoform. Thus, 
the B2 isoform can support some basal 
H+-ATPase activity in the plasma mem-
brane, but the B1 isoform is required for 
the stimulation of pump activity, as it 
occurs in settings of acid loading.
Fuster and colleagues16 (this issue) 
have overcome the problem of studying 
mutant B1 subunits in the background 
of cells expressing the B2 isoform by 
expressing wild-type and mutant human 
B1 isoforms in yeast cells that were 
engineered to lack all corresponding B 
isoforms. This elegant yeast complemen-
tation assay allowed them to examine 
the impact of B1 mutations detected in 
dRTA patients on assembly and func-
tion of the whole proton pump. Most 
mutations investigated disturbed assem-
bly of the proton pump domains. Some 
mutants showed apparently normal 
pump assembly but did not rescue the 
reduced growth of complemented yeast 
strains at alkaline pH, indicating that 
these mutants impaired pump activity 
despite normal assembly. Coexpression 
of wild-type and mutant B1 isoforms 
did not impair proton pump assem-
bly or function, in agreement with the 
autosomal recessive inheritance of this 
disease. Most interestingly, two alleles 
were investigated, the Thr30Ile and 
Glu161Lys alleles, that had been pre-
viously considered common polymor-
phisms. The Thr30Ile did not show any 
defects and can indeed be viewed as a 
polymorphism, whereas the Glu161Lys 
showed strongly impaired proton pump 
activity despite normal assembly. 
Some of these results are in contrast 
to previous investigations testing the 
impact of B1 and a4 isoform muta-
tions.17,18 These studies had also found 
evidence for impaired pump assembly 
Figure 1 | H+-ATPase expression along the collecting duct. Acid-secretory type A intercalated 
cells are localized along the collecting duct system from late distal convoluted tubule (DCT2) to 
the initial inner medullary collecting duct. Cytosolic carbonic anhydrase II (CA II) catalyzes the 
formation of bicarbonate and protons. Bicarbonate is released across the basolateral membrane 
into the pericapillary interstitium via chloride/bicarbonate exchanger(s), whereas protons are 
secreted into urine mainly by the vacuolar-type H+-ATPase (V-H+-ATPase) and to a lesser extent by 
H+/K+-ATPases. H+-ATPases are composed of two main sectors, the cytosolic V1 domain (depicted 
in orange) and the membrane-bound V0 domain (depicted in blue). ATP binds to the V1 domain, 
and its hydrolysis provides the energy to pump protons across the cell membrane-embedded 
V0 domain. Both domains are assembled from several subunits, often with many isoforms. Two 
isoforms of the B subunit exist, B1 (ATP6V1B1) and B2; the ‘a’ subunit exists in four isoforms 
(ATP6V0A1–4). Mutations in the B1 and a4 subunit isoforms, respectively, have been detected in 
patients with distal renal tubular acidosis due to the impaired proton secretion by proton pumps.
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and function but suggested that mutant 
B1 protein could exert a dominant-
negative effect on the assembly and 
trafficking of normal pumps when 
coexpressed. Some of the discrepan-
cies may be due to the fact that mutant 
isoforms were highly overexpressed and 
that a rat collecting duct cell line was 
used that expressed both normal B1 
and B2 isoforms.18 It will not be easy 
to resolve such discrepancies as long 
as we do not have good cell models at 
hand that resemble human interca-
lated cells. Furthermore, all models 
rely on the (over)expression of wild-
type or mutant proteins, which may 
alter stoichiometries between isoforms 
and alleles. Unfortunately, very little is 
known about expression of H+-ATPase 
subunits in the human kidney, as most 
studies were performed in rodent mod-
els, and no data are available on the 
situation in kidneys from patients with 
ATP6V1B1 mutations. 
The story resembles data obtained on 
the expression of wild-type and mutant 
AE1 proteins. Mutations in chloride/
anion exchanger AE1 (SLC4A1) cause 
autosomal dominant dRTA,19,20 as this 
transporter is expressed on the baso-
lateral side of intercalated cells of the 
kidney. Expression of mutants in renal 
cell lines indicated that in some instances 
loss of polarized expression due to traf-
ﬁcking of otherwise functional trans-
porters to the luminal side with possible 
bicarbonate wasting into urine would 
underlie the disease.21,22 Among these 
mutants is the S613F mutant, which is 
found on the apical membrane in over-
expressing cell lines. However, inves-
tigation of a rare biopsy from a dRTA 
patient with this mutation did not show 
any detectable luminal expression of the 
mutant but rather showed intracellular 
or even absent staining.23 Thus, data 
from overexpression systems should be 
taken with great caution. What are the 
alternatives? The generation of human-
ized mouse models that do not lack the 
gene of interest but express the mutant 
gene recapitulating human muta-
tions may be an additional useful tool, 
although not suited for high-through-
put screening of mutations. Tissues or 
cells from patients would be another 
attractive way; however, although the 
attempts to raise good renal cell lines are 
numerous, little progress has been made. 
Yeast cell lines as used by Fuster et al.16 
are another alternative, as, in the case of 
proton pumps, much is known about the 
biology of yeast vacuolar-type ATPases, 
genetic models lacking subunits of the 
yeast pump, and easy complementation 
assays are at hand.
The work of Fuster and colleagues16 
goes beyond investigating the direct 
impact of B1 mutations on pump assem-
bly and function. The authors suggest 
that alleles viewed as polymorphisms 
of proton pump subunits may actually 
be genuine mutations impairing uri-
nary acidiﬁcation. In view of the link 
between reduced urinary acidiﬁcation 
and calcium stone formation, it may be 
quite worthwhile to take a closer look 
at such polymorphisms found in these 
patients. Even though full-blown dRTA 
is caused only in the presence of two 
mutated alleles, it may be enough to 
carry one dysfunctional allele to reduce 
urinary acidiﬁcation to an extent suﬃ-
cient to increase the risk of kidney stone 
formation.
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